http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27460814

Outgoing Links

Predicate Object
contentType Comparative Study|Journal Article|Review
endingPage 533
issn 1354-3784
1744-7658
issueIdentifier 4
pageRange 521-533
publicationName Expert Opinion on Investigational Drugs
startingPage 521
bibliographicCitation Bannwarth B, Berenbaum F. Clinical pharmacology of lumiracoxib, a second-generation cyclooxygenase 2 selective inhibitor. Expert Opin Investig Drugs. 2005 Apr;14(4):521–33. doi: 10.1517/13543784.14.4.521. PMID: 15882125.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_77058f725250ef729dabe08db83f54d3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2017a39a474e8d4c65057d70bfba4082
date 200504
identifier https://pubmed.ncbi.nlm.nih.gov/15882125
https://doi.org/10.1517/13543784.14.4.521
isPartOf https://portal.issn.org/resource/ISSN/1744-7658
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21889
https://portal.issn.org/resource/ISSN/1354-3784
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Clinical pharmacology of lumiracoxib, a second-generation cyclooxygenase 2 selective inhibitor
discusses http://id.nlm.nih.gov/mesh/M0006284
http://id.nlm.nih.gov/mesh/M0446346
http://id.nlm.nih.gov/mesh/M0001335
http://id.nlm.nih.gov/mesh/M0450698
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D004008Q000031
http://id.nlm.nih.gov/mesh/D052246Q000494
http://id.nlm.nih.gov/mesh/D052246Q000627
hasSubjectTerm http://id.nlm.nih.gov/mesh/D004008Q000494
http://id.nlm.nih.gov/mesh/D004412Q000517
http://id.nlm.nih.gov/mesh/D004008Q000627
http://id.nlm.nih.gov/mesh/D004008Q000009
http://id.nlm.nih.gov/mesh/D010149Q000517
http://id.nlm.nih.gov/mesh/D016032
http://id.nlm.nih.gov/mesh/D052246Q000009
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D000894Q000009
http://id.nlm.nih.gov/mesh/D010003Q000188
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D001172Q000188
http://id.nlm.nih.gov/mesh/D006471Q000209
http://id.nlm.nih.gov/mesh/D000894Q000627
http://id.nlm.nih.gov/mesh/D000894Q000494
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID156391
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_25e7482d087cb6429609f07a507aa159
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5090
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151166
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9412
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8830
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8722
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11360
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8096
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7516
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6965
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9537
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10602
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6969
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7987
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2662
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3672

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127648365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129202881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129203714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128383506
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128514984
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127715174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128048219

Total number of triples: 73.